Science · 20 views
EV-SELEX speeds GPCR drug discovery by capturing receptor-bound DNA aptamers
G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse physiological processes ranging from pain perception to hormone signaling.
AI Summary
Researchers have developed a new method for accelerating the discovery of drugs targeting G protein-coupled receptors (GPCRs). This approach, known as EV-SELEX, involves capturing DNA aptamers that bind to GPCRs. The significance of this development lies in the central role GPCRs play in regulating various physiological processes. As the most abundantly expressed proteins in the human body, they are a primary target for many new drugs in development. This method may streamline the process of identifying potential drug candidates, potentially leading to more efficient development of treatments for a range of conditions.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Science
Continue reading recent Science coverage
- As antibiotic resistance grows, researchers turn to copper to fight infectionsContinue reading
- Nepal flood disaster exposes cascading threats in HimalayasContinue reading
- Elephants Just Passed a Classic Psychology Test – With More Restraint Than Many HumansContinue reading
- Q&A: The origin of 'OnlyMarms' and what made it a roaring successContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow